Faced with global giants such as Roche, Abbott and Thermo Fischer, Eurofins intends to gain a prominent place in the coveted market for coronavirus tests. And it gives itself the means. The French test specialist has just raised 535 million euros. This operation was carried out by issuing 1 million new shares to institutional investors at a price of 535 euros per share.
Read also: Many French people get tested to find out if they have had the virus
This represents a discount of 7.2% compared to the closing price on Monday. And this, while the title of the company is at its highest for almost two years. "The success of this operation demonstrates the confidence of investors in our ability to use our capital to create value for our shareholders," said Gilles Martin, CEO of Eurofins, who founded the company some 30 years ago. years. This fundraising comes ten days after an early debt refinancing operation by the French company.
Full range
This funding is intended to increase
This article is for subscribers only. You have 70% left to discover.
Subscribe: € 1 the first month
cancellable at any time
Enter your emailAlready subscribed? Log in